Flinn announced a $20 million fundraising round to accelerate development of artificial intelligence tools for product lifecycle management in the medtech and pharmaceutical sectors. The capital will be used to build AI-driven solutions that streamline design, compliance, and market launch processes. The round underscores growing investor interest in AI applications within healthcare.
Comments
Want to join the conversation?
Loading comments...